Navigation Links
Cambrex Presentation at The JPMorgan Healthcare Conference to be Webcast
Date:1/5/2009

EAST RUTHERFORD, N.J., Jan. 5 /PRNewswire-FirstCall/ -- Cambrex Corporation (NYSE: CBM) is pleased to announce that Steven M. Klosk, President and Chief Executive Officer, will be presenting at the JPMorgan Healthcare Conference on January 13, 2009 at 9:00 a.m. PST at the Westin St. Francis, San Francisco, California.

(Logo: http://www.newscom.com/cgi-bin/prnh/20000613/CAMBREXLOGO )

A live webcast of the presentation will be accessible during the conference from http://metameetings.com/webcasts/jpmorgan/healthcare09/directlink?ticker=CBM. An archive of the presentation will be available for approximately 90 days after the conference.

The webcast and the slide presentation can also be accessed from the Cambrex website www.cambrex.com in the Webcasts section of the Investor Relations page.

About Cambrex

Cambrex provides products and services to accelerate the development and commercialization of small molecule therapeutics including active pharmaceutical ingredients ("APIs"), advanced intermediates, enhanced drug delivery and other products for branded and generic pharmaceuticals. The Company currently employs approximately 850 people worldwide. For more information, please visit http://www.cambrex.com.


'/>"/>
SOURCE Cambrex Corporation
Copyright©2009 PR Newswire.
All rights reserved

Page: 1

Related medicine news :

1. Cambrex To Announce Third Quarter 2007 Financial Results on November 1, 2007
2. Cambrex Signs Agreement To Acquire ProSyntest AS
3. Cambrex Reports Fourth Quarter and Full-Year 2007 Results
4. Cambrex Customer Announced Recall
5. Cambrex to Announce First Quarter 2008 Financial Results on May 1, 2008
6. Mettler-Toledo International Inc. Announces Webcast of Presentation at Thomas Weisel Partners 2007 Healthcare Conference
7. Bear Stearns 20th Annual Healthcare Conference to Webcast Millennium Presentation
8. Exelixis Announces September 18 Webcast of Presentation at the Bank of America 2007 Investment Conference
9. Rohm and Haas to Webcast Presentation at Credit Suisse Chemicals Conference
10. Haemonetics Webcast Presentation
11. Presentation at Bio Contact Quebec 2007
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/23/2017)... (PRWEB) , ... August 23, 2017 , ... ... of the American Academy of Orthopaedic Surgeons , points out that therapeutic ... suffering from pain or injury. According to the report, a wider scope of ...
(Date:8/22/2017)... ... 22, 2017 , ... The old adage “you are what ... eating healthy foods. But this well-known piece of nutrition advice ignores that an ... carbohydrates—depends not only on properties of the food but also on properties of ...
(Date:8/22/2017)... del Rey, CA (PRWEB) , ... August 22, ... ... of revenue cycle management (RCM) solutions, announced recently the availability of a new ... HIM community in appreciation for their service to the healthcare industry. E/M coding ...
(Date:8/22/2017)... ... ... “Wilderness Voices”: a collection of poetry inspired by life on a Kentucky ... published author, Martha McKown, an ordained United Methodist minister with graduate degrees in Religious ... her older sisters studied High School literature. She loved the early English folk ...
(Date:8/22/2017)... ... August 22, 2017 , ... ... is the Founder and Managing Member for t4 Leadership Development & Consulting. He ... to his definition of “success”: physician leadership development, servant leadership, data driven process ...
Breaking Medicine News(10 mins):
(Date:8/15/2017)... Inc. announced today that its fully owned USA ... York City Office in Yonkers, New York ... (TWO 2 ) homecare therapy. This new East Coast location has ... under the company,s DMEPOS accreditation for Home/Durable Medical Equipment Services. ... Advanced Oxygen Therapy Inc. New ...
(Date:8/11/2017)... 11, 2017 DarioHealth Corp. (NASDAQ: DRIO), a ... big data solutions, today announced that it will release ... and host a conference call at 9:00am ET. The ... financial results and its strategy and outlook for the ... Erez Raphael , Chief Executive Officer, and ...
(Date:8/8/2017)... Aug. 8, 2017  BioLineRx Ltd. (NASDAQ/TASE: BLRX), a ... reports its financial results for the second quarter ended ... the second quarter 2017 and to date: ... development programs for the Company,s lead project, BL-8040: ... study with BL-8040 as novel stem cell mobilization treatment ...
Breaking Medicine Technology: